Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	351-363
Number of pages	13
Journal	European Journal of Pharmacology
Volume	815
DOIs	https://doi.org/10.1016/j.ejphar.2017.09.022
Publication status	Published - 15 Nov 2017

6-OHDA, Levodopa, MPTP, Parkinson disease, Rotenone, Terpene, SERIES, RATS, MOUSE MODEL, DISEASE, ANIMAL-MODELS, MICE, BRAIN, Antiparkinson Agents/pharmacology, Oxotremorine/pharmacology, Mice, Inbred C57BL, Reserpine/pharmacology, Parkinsonian Disorders/drug therapy, Male, Cyclohexanols/pharmacology, Catalepsy/drug therapy, Animals, Mice, Disease Models, Animal

ID: 8968373